Cite

HARVARD Citation

    Xiao, Y. et al. (2018). FBXW7 deletion contributes to lung tumor development and confers resistance to gefitinib therapy. Molecular oncology. 12 (6), pp. 883-895. [Online]. 
  
Back to record